1. Home
  2. RZLT vs UHG Comparison

RZLT vs UHG Comparison

Compare RZLT & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • UHG
  • Stock Information
  • Founded
  • RZLT 2010
  • UHG 2004
  • Country
  • RZLT United States
  • UHG United States
  • Employees
  • RZLT N/A
  • UHG N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • UHG Homebuilding
  • Sector
  • RZLT Health Care
  • UHG Consumer Discretionary
  • Exchange
  • RZLT Nasdaq
  • UHG Nasdaq
  • Market Cap
  • RZLT 819.3M
  • UHG 248.7M
  • IPO Year
  • RZLT N/A
  • UHG N/A
  • Fundamental
  • Price
  • RZLT $9.98
  • UHG $1.57
  • Analyst Decision
  • RZLT Strong Buy
  • UHG
  • Analyst Count
  • RZLT 7
  • UHG 0
  • Target Price
  • RZLT $14.86
  • UHG N/A
  • AVG Volume (30 Days)
  • RZLT 1.4M
  • UHG 647.6K
  • Earning Date
  • RZLT 11-07-2025
  • UHG 11-06-2025
  • Dividend Yield
  • RZLT N/A
  • UHG N/A
  • EPS Growth
  • RZLT N/A
  • UHG N/A
  • EPS
  • RZLT N/A
  • UHG 0.10
  • Revenue
  • RZLT N/A
  • UHG $445,963,017.00
  • Revenue This Year
  • RZLT N/A
  • UHG N/A
  • Revenue Next Year
  • RZLT N/A
  • UHG N/A
  • P/E Ratio
  • RZLT N/A
  • UHG $16.64
  • Revenue Growth
  • RZLT N/A
  • UHG 7.51
  • 52 Week Low
  • RZLT $2.22
  • UHG $1.59
  • 52 Week High
  • RZLT $10.04
  • UHG $6.93
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 63.37
  • UHG 19.97
  • Support Level
  • RZLT $9.00
  • UHG $1.65
  • Resistance Level
  • RZLT $10.00
  • UHG $4.78
  • Average True Range (ATR)
  • RZLT 0.56
  • UHG 0.22
  • MACD
  • RZLT 0.04
  • UHG -0.14
  • Stochastic Oscillator
  • RZLT 91.82
  • UHG 0.00

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About UHG United Homes Group Inc

United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.

Share on Social Networks: